Skip to main content

Tweets

Enhance your clinical practice with insights from the EULAR 2024 Poster Hall Presentations, now on https://t.co/V10S4oVFsv. This year's conference showcases pivotal research in rheumatology. Visit https://t.co/58cJsSROsE to stay at the forefront of medical innovation. https://t.co/jbbufRQ6MW
Dr. John Cush @RheumNow ( View Tweet )
15 hours 1 minute ago
Rituximab vs. Tocilizimab for Scleroderma: Which is Better? Dr. Janet Pope discusses abstract OP0295 presented at Eular 2024 in Vienna, Austria. https://t.co/70YF2wxwj5 https://t.co/8BHCafFs3u
Dr. John Cush @RheumNow ( View Tweet )
17 hours 1 minute ago
Has JAK POT Hit the Spot About Infection Risk? Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria. https://t.co/vN2VZYGqbE https://t.co/MQ3QCJU4SW
Dr. John Cush @RheumNow ( View Tweet )
19 hours 1 minute ago
Does Withdrawing Steroids Increase Flares in SLE? Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria. https://t.co/FjS0MBeWkv https://t.co/jeoO0gzz0K
Dr. John Cush @RheumNow ( View Tweet )
21 hours 1 minute ago
DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria. https://t.co/gKJRygBeq0 https://t.co/2NTNYJLPNZ
Dr. John Cush @RheumNow ( View Tweet )
1 day 11 hours ago
Damage in Childhood Lupus Childhood lupus (cSLE) is a rare multisystem disorder with significant associated morbidity, but evidence-based guidelines are sparse, and as such management is often based on clinical expertise. https://t.co/wCygK0LGvd https://t.co/tm8LTI28mh
Dr. John Cush @RheumNow ( View Tweet )
1 day 12 hours ago
RA: update for women of child bearing potential (and men!) Fertility in the context of RMDs is a daily concern for a lot of rheumatologists and patients. https://t.co/RrkR2V3CI3 https://t.co/CRXUKxUqF2
Dr. John Cush @RheumNow ( View Tweet )
1 day 13 hours ago
Difficult-to-treat Rheumatoid Arthritis: Validation of the EULAR Definition Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria. https://t.co/oc3Aj60KsM https://t.co/40FMjbKEHF
Dr. John Cush @RheumNow ( View Tweet )
1 day 14 hours ago
EULAR 2024 Daily Recap: Days 1 & 2 Dr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria. https://t.co/gRMVUXhTxw https://t.co/YV8vjVUCJn
Dr. John Cush @RheumNow ( View Tweet )
1 day 15 hours ago
Rituximab to Treat Systemic Features of Sjogren's Dr. Yuz Yusof discusses abstract OP0076 presented at Eular 2024 in Vienna, Austria. https://t.co/9oJNz12cCI https://t.co/bZxpbf3PT9
Dr. John Cush @RheumNow ( View Tweet )
1 day 16 hours ago
Update on Sjogren's disease trials With better endpoint and patient selection strategy over the last 4 years, many new therapies have met their endpoints/shown promising signal in the Phase 2 RCTs in Sjogren's disease. https://t.co/qMxEX73BsM https://t.co/CQWaAIO4IK
Dr. John Cush @RheumNow ( View Tweet )
1 day 17 hours ago
New Treatments for Systemic Sclerosis aHSCT for SSc has been proven the most effective treatment strategy with regard to overall and event free survival in selected patients.2 But a key limitation is its toxicity, and new treatment options are needed. https://t.co/xUI0plrk42 https://t.co/DqGUhU6D1Z
Dr. John Cush @RheumNow ( View Tweet )
1 day 18 hours ago